Literature DB >> 33005013

Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases.

Sang-Min Jang1, Christophe E Redon2, Bhushan L Thakur2, Meriam K Bahta2, Mirit I Aladjem3.   

Abstract

The last decade has revealed new roles for Cullin-RING ubiquitin ligases (CRLs) in a myriad of cellular processes, including cell cycle progression. In addition to CRL1, also named SCF (SKP1-Cullin 1-F box protein), which has been known for decades as an important factor in the regulation of the cell cycle, it is now evident that all eight CRL family members are involved in the intricate cellular pathways driving cell cycle progression. In this review, we summarize the structure of CRLs and their functions in driving the cell cycle. We focus on how CRLs target key proteins for degradation or otherwise alter their functions to control the progression over the various cell cycle phases leading to cell division. We also summarize how CRLs and the anaphase-promoting complex/cyclosome (APC/C) ligase complex closely cooperate to govern efficient cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33005013      PMCID: PMC8080560          DOI: 10.1038/s12276-020-00508-4

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  124 in total

Review 1.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

2.  Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.

Authors:  Tarig Bashir; N Valerio Dorrello; Virginia Amador; Daniele Guardavaccaro; Michele Pagano
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

3.  The SLX4 complex is a SUMO E3 ligase that impacts on replication stress outcome and genome stability.

Authors:  Jean-Hugues Guervilly; Arato Takedachi; Valeria Naim; Sarah Scaglione; Charly Chawhan; Yoann Lovera; Emmanuelle Despras; Isao Kuraoka; Patricia Kannouche; Filippo Rosselli; Pierre-Henri L Gaillard
Journal:  Mol Cell       Date:  2014-12-18       Impact factor: 17.970

4.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

5.  Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.

Authors:  Z K Yu; J L Gervais; H Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 6.  Coupling Conjugation and Deconjugation Activities to Achieve Cellular Ubiquitin Dynamics.

Authors:  Casey P Nielsen; Jason A MacGurn
Journal:  Trends Biochem Sci       Date:  2020-02-28       Impact factor: 13.807

7.  The CRL4Cdt2 ubiquitin ligase mediates the proteolysis of cyclin-dependent kinase inhibitor Xic1 through a direct association with PCNA.

Authors:  Dong Hyun Kim; Varija N Budhavarapu; Carlos R Herrera; Hyung Wook Nam; Yu Sam Kim; P Renee Yew
Journal:  Mol Cell Biol       Date:  2010-07-06       Impact factor: 4.272

Review 8.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

9.  Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation.

Authors:  Takumi Kamura; Taichi Hara; Shuhei Kotoshiba; Masayoshi Yada; Noriko Ishida; Hiroyuki Imaki; Shigetsugu Hatakeyama; Keiko Nakayama; Keiichi I Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

Review 10.  Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.

Authors:  Sang-Min Jang; Christophe E Redon; Mirit I Aladjem
Journal:  Front Mol Biosci       Date:  2018-03-13
View more
  5 in total

1.  A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy.

Authors:  Iqra Bano; Moolchand Malhi; Min Zhao; Liviu Giurgiulescu; Hira Sajjad; Marek Kieliszek
Journal:  3 Biotech       Date:  2022-03-29       Impact factor: 2.406

Review 2.  Diabetic Muscular Atrophy: Molecular Mechanisms and Promising Therapies.

Authors:  Yuntian Shen; Ming Li; Kexin Wang; Guangdong Qi; Hua Liu; Wei Wang; Yanan Ji; Mengyuan Chang; Chunyan Deng; Feng Xu; Mi Shen; Hualin Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

3.  Mutual inactivation of two RING-finger-type E3 ubiquitin ligases during cell cycle progression.

Authors:  Shizhen Zhang; Yi Sun
Journal:  Mol Cell Oncol       Date:  2020-12-15

Review 4.  CRL4Cdt2 Ubiquitin Ligase, A Genome Caretaker Controlled by Cdt2 Binding to PCNA and DNA.

Authors:  Muadz Ahmad Mazian; Kumpei Yamanishi; Mohd Zulhilmi Abdul Rahman; Menega Ganasen; Hideo Nishitani
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096

Review 5.  Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer.

Authors:  Trace M Jones; Jennifer S Carew; Julie E Bauman; Steffan T Nawrocki
Journal:  Cancers (Basel)       Date:  2021-06-29       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.